| dc.contributor.author | Araz-Ersan, Bilge | |
| dc.contributor.author | Gül, Ahmet | |
| dc.contributor.author | Aydinoglu-Candan, Ozlem | |
| dc.contributor.author | Tugal-Tutkun, Ilknur | |
| dc.contributor.author | Badur, Selim | |
| dc.date.accessioned | 2021-03-04T08:49:12Z | |
| dc.date.available | 2021-03-04T08:49:12Z | |
| dc.date.issued | 2015 | |
| dc.identifier.citation | Aydinoglu-Candan O., Araz-Ersan B., Gül A., Badur S., Tugal-Tutkun I., "Anti-interferon alpha antibodies and autoantibodies in patients with Beh double dagger et's disease uveitis treated with recombinant human interferon alpha-2a", GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, cilt.253, sa.3, ss.457-465, 2015 | |
| dc.identifier.issn | 0721-832X | |
| dc.identifier.other | av_652846fd-8f30-40d6-9693-87fea8312e56 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/70352 | |
| dc.identifier.uri | https://doi.org/10.1007/s00417-014-2856-3 | |
| dc.description.abstract | Recombinant human (rh) interferon alpha2a (IFN-alpha 2a) therapy is successfully used for the treatment of Beh double dagger et's disease (BD) uveitis refractory to conventional immunosuppressive treatment. | |
| dc.language.iso | eng | |
| dc.subject | Göz Hastalıkları ve Cerrahisi | |
| dc.subject | Cerrahi Tıp Bilimleri | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | OFTALMOLOJİ | |
| dc.title | Anti-interferon alpha antibodies and autoantibodies in patients with Beh double dagger et's disease uveitis treated with recombinant human interferon alpha-2a | |
| dc.type | Makale | |
| dc.relation.journal | GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | |
| dc.contributor.department | İstanbul Üniversitesi , , | |
| dc.identifier.volume | 253 | |
| dc.identifier.issue | 3 | |
| dc.identifier.startpage | 457 | |
| dc.identifier.endpage | 465 | |
| dc.contributor.firstauthorID | 25010 | |
